-
VINC Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Vincerx Pharma (VINC)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 3.03 mm | 3.03 mm | 3.03 mm | 3.03 mm | 3.03 mm | 3.03 mm |
Cash burn (monthly) | 1.66 mm | 1.01 mm | 2.60 mm | 2.35 mm | 2.13 mm | 2.33 mm |
Cash used (since last report) | 7.29 mm | 4.44 mm | 11.41 mm | 10.31 mm | 9.34 mm | 10.24 mm |
Cash remaining | -4.26 mm | -1.41 mm | -8.38 mm | -7.29 mm | -6.31 mm | -7.21 mm |
Runway (months of cash) | -2.6 | -1.4 | -3.2 | -3.1 | -3.0 | -3.1 |
13F holders | Current |
---|---|
Total holders | 30 |
Opened positions | 28 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 8.27 bn |
Total shares | 13.34 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Prosight Management | 2.49 mm | $2.02 bn |
Armistice Capital | 1.99 mm | $1.61 bn |
Sage Rhino Capital | 1.70 mm | $1.38 bn |
LifeSci Investments | 1.62 mm | $0.00 |
Tang Capital Partners | 1.03 mm | $0.00 |
Rock Springs Capital Management | 891.72 k | $722.29 mm |
Point72 Asset Management | 674.19 k | $546.10 mm |
GS The Goldman Sachs Group, Inc. | 631.42 k | $511.45 mm |
Vanguard | 627.44 k | $508.23 mm |
ExodusPoint Capital Management | 477.95 k | $387.00 k |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
12 Aug 24 | Raquel E. Izumi | Stock Option Common Stock | Grant | Acquire A | No | No | 0.55 | 41,250 | 22.69 k | 165,000 |
12 Aug 24 | Raquel E. Izumi | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 7.38 | 41,250 | 304.43 k | 0 |
12 Aug 24 | Raquel E. Izumi | Stock Option Common Stock | Grant | Acquire A | No | No | 0.55 | 123,750 | 68.06 k | 123,750 |
12 Aug 24 | Raquel E. Izumi | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 7.38 | 123,750 | 913.28 k | 0 |
12 Aug 24 | Raquel E. Izumi | Stock Option Common Stock | Grant | Acquire A | No | No | 0.55 | 90,000 | 49.50 k | 90,000 |
12 Aug 24 | Raquel E. Izumi | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 1.17 | 90,000 | 105.30 k | 0 |
12 Aug 24 | Raquel E. Izumi | Stock Option Common Stock | Grant | Acquire A | No | No | 0.55 | 60,000 | 33.00 k | 60,000 |
12 Aug 24 | Raquel E. Izumi | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 0.82 | 60,000 | 49.20 k | 0 |
12 Aug 24 | Raquel E. Izumi | Stock Option Common Stock | Grant | Acquire A | No | No | 0.55 | 60,000 | 33.00 k | 60,000 |
12 Aug 24 | Raquel E. Izumi | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 1.71 | 60,000 | 102.60 k | 0 |